• Media type: E-Article
  • Title: To Lighten the Burden of Cure: Thyroid Disease in Long-Term Survivors After TBI Conditioning for Paediatric ALL
  • Contributor: Zubarovskaya, Natalia; Bauer, Dorothea; Ronceray, Leila; Poetschger, Ulrike; Kurzmann, Paulina; Lender, Carina; Kuzmina, Zoya; Lawitschka, Anita
  • imprint: Frontiers Media SA, 2022
  • Published in: Frontiers in Pediatrics
  • Language: Not determined
  • DOI: 10.3389/fped.2021.798974
  • ISSN: 2296-2360
  • Origination:
  • Footnote:
  • Description: <jats:p>Thyroid disorders are well-studied after allogeneic haematopoietic stem cell transplantation (HSCT) following total body irradiation (TBI)-based conditioning, occurring in 15–30% of paediatric survivors. The toxic effect of TBI is known but data on the role of immunological dysregulation (ID) and chronic graft-versus-host-disease (cGvHD) are scarce. We studied functional and structural thyroid disorders in 97 paediatric ALL patients after TBI-based HSCT, assessing their correlation with patient/transplant characteristics including cGvHD, prolonged immunosuppression and ID. The 10- and 15-year cumulative incidence (CI) of functional disorders was 50 and 60%. Univariate analysis revealed TBI in 6 vs. 8 fractions (<jats:italic>p</jats:italic> = 0.01), an interval between ALL diagnosis and HSCT &amp;lt;1 year (<jats:italic>p</jats:italic> = 0.038), and the application of ATG (<jats:italic>p</jats:italic> = 0.044) as risk factors. The 10- and 15-year CI of structural disorders was 60 and 80%. No correlation between patient/transplant characteristics and structural disorders was observed. cGvHD, prolonged immunosuppression and additional radiotherapy were not associated with any thyroid disease. We observed a significant correlation between ID and the development of thyroid dysfunction in patients with structural changes (10-year CI: 77% for patients with ID vs. 56% without ID, <jats:italic>p</jats:italic> = 0.02). The impact of our results on thyroid follow-up evaluations and the significance of hormonal replacement therapy are discussed.</jats:p>
  • Access State: Open Access